细胞外囊泡作为急性移植物抗宿主病的潜在生物标志物
探索性研究从41例接受异基因移植的多发性骨髓瘤患者血清中提取细胞外囊泡(EVs),用13种抗体经流式细胞术检测EV表面抗原与急性GVHD的相关性。Logistic回归和Cox比例风险模型均显示3种EV表面生物标志物与急性GVHD发生相关。CD146与发生GVHD风险增加近60%相关,CD31和CD140-α分别与风险降低近40%和60%相关。
要点
- CD146(MCAM-1)表达与急性GVHD风险增加近60%相关
- CD31和CD140-α分别与急性GVHD风险降低近40%和60%相关
- 3种EV表面标志物从基线至急性GVHD发生时信号水平显著变化
核心结论
- EV表面表达的CD146、CD31和CD140-α与急性GVHD发生相关,值得未来进一步研究。
研究设计与样本
- 探索性研究,从41例接受异基因移植的多发性骨髓瘤患者血清样本中提取EVs。
- 用13种针对特定膜蛋白的抗体经流式细胞术对EVs进行表征。
主要发现
- Logistic回归分析和Cox比例风险模型均显示3种EV表面潜在生物标志物与急性GVHD发生相关。
- CD146(MCAM-1)与发生GVHD风险增加近60%相关。
- CD31(PECAM-1)与发生GVHD风险降低近40%相关。
- CD140-α(PDGFR-α)与发生GVHD风险降低近60%相关。
- 这些生物标志物从基线至急性GVHD发生时信号水平显著变化。
局限性
- 本研究为探索性研究,作者鼓励未来进一步研究EVs与急性GVHD之间的潜在相关性。
- 更大规模的前瞻性多中心研究正在进行中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute graft-vs-host disease (GVHD) is a serious complication after allografting. We carried out an exploratory study to investigate a potential correlation of surface antigens on extracellular vesicles (EVs) and acute GVHD. EVs were extracted from serum samples from 41 multiple myeloma patients who underwent allografting. EVs were characterized by flow cytometry using a panel of 13 antibodies against specific membrane proteins that were reported to be predictive of acute GVHD. We observed a correlation between three potential biomarkers expressed on EV surface and acute GVHD onset by both logistic regression analysis and Cox proportional hazard model. In our study, CD146 (MCAM-1) was correlated with an increased risk-by almost 60%-of developing GVHD, whereas CD31 and CD140-α (PECAM-1 and PDGFR-α) with a decreased risk-by almost 40 and 60%, respectively. These biomarkers also showed a significant change in signal level from baseline to the onset of acute GVHD. Our novel study encourages future investigations into the potential correlation between EVs and acute GVHD. Larger prospective multicenter studies are currently in progress.
引用
- Lia G, Brunello L, Bruno S, et al. Extracellular vesicles as potential biomarkers of acute graft-vs-host disease. Leukemia. 2017. PMID: 28852198. doi:10.1038/leu.2017.277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。